Cargando…

First person – Sukalp Muzumdar

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sukalp Muzumdar is first author on ‘Genetic activation of Nrf2 reduces cutaneous symptoms i...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272333/
http://dx.doi.org/10.1242/dmm.045146
_version_ 1783542231290871808
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sukalp Muzumdar is first author on ‘Genetic activation of Nrf2 reduces cutaneous symptoms in a murine model of Netherton syndrome’, published in DMM. Sukalp conducted the research described in this article while a PhD student in the lab of Prof. Dr Sabine Werner and PD Dr Matthias Schäfer at ETH Zurich, Zurich, Switzerland. He is now a postdoctoral fellow in the lab of Jesse Gillis at Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA, investigating the mechanisms behind rare diseases and exploring avenues for novel treatments.
format Online
Article
Text
id pubmed-7272333
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-72723332020-06-05 First person – Sukalp Muzumdar Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sukalp Muzumdar is first author on ‘Genetic activation of Nrf2 reduces cutaneous symptoms in a murine model of Netherton syndrome’, published in DMM. Sukalp conducted the research described in this article while a PhD student in the lab of Prof. Dr Sabine Werner and PD Dr Matthias Schäfer at ETH Zurich, Zurich, Switzerland. He is now a postdoctoral fellow in the lab of Jesse Gillis at Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA, investigating the mechanisms behind rare diseases and exploring avenues for novel treatments. The Company of Biologists Ltd 2020-05-29 /pmc/articles/PMC7272333/ http://dx.doi.org/10.1242/dmm.045146 Text en © 2020. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Sukalp Muzumdar
title First person – Sukalp Muzumdar
title_full First person – Sukalp Muzumdar
title_fullStr First person – Sukalp Muzumdar
title_full_unstemmed First person – Sukalp Muzumdar
title_short First person – Sukalp Muzumdar
title_sort first person – sukalp muzumdar
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272333/
http://dx.doi.org/10.1242/dmm.045146